Sonoma Pharmaceuticals, Inc. (SNOA)

Sonoma Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Net Income	-4.84	-4.84	-5.15	-5.09	-3.95	-3.31
Depreciation & Amortization	0.18	0.18	0.13	0.19	0.23	0.31
Share-Based Compensation	0.52	0.52	0.67	0.38	0.37	0.84
Other Operating Activities	1.75	1.75	-1.8	0.27	-0.03	-2.43
Operating Cash Flow	-2.4	-2.4	-6.15	-4.25	-3.38	-4.59
Capital Expenditures	-0.02	-0.02	-0.27	-0.14	-0.18	-0.21
Acquisitions	0	0	0	0	0.61	3.8
Change in Investments	0.02	0.02	0.01	0.04	-0.04	0.05
Investing Cash Flow	-0	-0	-0.26	-0.1	0.39	3.64
Share Issuance / Repurchase	1.78	1.78	2.87	7.77	2.29	1.38
Debt Issued / Paid	-0.48	-0.48	-0.89	-0.37	0.83	-0.33
Other Financing Activities	0.37	0.37	0.52	-	0.19	-0.01
Financing Cash Flow	1.68	1.68	2.49	7.4	3.31	1.03
Exchange Rate Effect	0.03	0.03	0.35	0.13	0.21	-0.08
Net Cash Flow	-0.69	-0.69	-3.58	3.18	0.53	0
Free Cash Flow	-2.42	-2.42	-6.42	-4.39	-3.56	-4.8
Free Cash Flow Margin	-18.96%	-18.96%	-48.38%	-34.72%	-19.09%	-26.76%
Free Cash Flow Per Share	-0.27	-0.27	-1.89	-1.65	-1.78	-3.25

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).